Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application
Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application
Optimi Health Notes Lykos Therapeutics 和 FDA 對新藥申請
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊